WP
Woodline Partners Portfolio holdings
AUM
$25.8B
1-Year Est. Return
36.53%
This Fund
S&P 500
1 Year Est. Return
+36.53%
AUM
$25.8B
AUM Growth
+$4.56B
(+21%)
Holding
1,157
Top Buys
| 1 | +$997M | |
| 2 | +$215M | |
| 3 | +$209M | |
| 4 |
Verizon
VZ
|
+$208M |
| 5 |
Amphenol
APH
|
+$143M |
Top Sells
| 1 | +$200M | |
| 2 | +$158M | |
| 3 | +$141M | |
| 4 |
Chubb
CB
|
+$115M |
| 5 |
argenx
ARGX
|
+$106M |
Sector Composition
| 1 | Healthcare | 24.17% |
| 2 | Technology | 23.31% |
| 3 | Financials | 10.75% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Amgen
AMGN
$199B
| $59.4M | 0.23% |
181,454
+29,548
|
|
||
102
Incyte
INCY
$19.1B
| $59.3M | 0.23% |
600,642
+254,478
|
|
||
103
Quest Diagnostics
DGX
$21.9B
| $59.2M | 0.23% |
341,372
+223,936
|
|
||
104
Brinker International
EAT
$5.87B
| $59M | 0.23% |
+410,862
|
|
||
105
Blackrock
BLK
$148B
| $58.5M | 0.23% |
54,639
+35,605
|
|
||
106
Vertex Pharmaceuticals
VRTX
$116B
| $57.9M | 0.22% |
127,726
-25,546
|
|
||
107
UDR
UDR
$12.2B
| $57.7M | 0.22% |
1,572,297
+1,532,521
|
|
||
108
Bristol-Myers Squibb
BMY
$123B
| $57.7M | 0.22% |
1,069,117
+78,866
|
|
||
109
Gilead Sciences
GILD
$179B
| $57.4M | 0.22% |
467,295
+27,393
|
|
||
110
Oracle
ORCL
$440B
| $56.6M | 0.22% |
290,504
+71,480
|
|
||
111
Ollie's Bargain Outlet
OLLI
$6.68B
| $56.4M | 0.22% |
+514,402
|
|
||
112
Terns Pharmaceuticals
TERN
$4.66B
| $55.6M | 0.22% |
1,377,283
+1,085,228
|
|
||
113
Chewy
CHWY
$10.6B
| $55.1M | 0.21% |
1,667,186
+276
|
|
||
114
ATI
ATI
$20.6B
| $54.1M | 0.21% |
471,195
-275,932
|
|
||
115
Scholar Rock
SRRK
$4.62B
| $53.3M | 0.21% |
1,211,088
+340,038
|
|
||
116
GlobalFoundries
GFS
$26.1B
| $52.6M | 0.2% |
1,506,989
+396,858
|
|
||
117
Home Depot
HD
$356B
| $52.5M | 0.2% |
152,683
+21,192
|
|
||
118
Cisco
CSCO
$311B
| $51.8M | 0.2% |
672,587
-437,346
|
|
||
119
Applied Materials
AMAT
$258B
| $51.7M | 0.2% |
201,284
-67,212
|
|
||
120
Soleno Therapeutics
SLNO
$2.13B
| $51.5M | 0.2% |
1,111,778
+840,946
|
|
||
121
Carrier Global
CARR
$48.8B
| $51.2M | 0.2% |
969,529
+940,654
|
|
||
122
Sotera Health
SHC
$4.17B
| $50.9M | 0.2% |
2,883,807
+2,353,083
|
|
||
123
Paycom
PAYC
$7.34B
| $50.8M | 0.2% |
318,516
+37,686
|
|
||
124
Vera Therapeutics
VERA
$2.79B
| $50.7M | 0.2% |
1,000,279
+262,701
|
|
||
125
Becton Dickinson
BDX
$47.5B
| $50.5M | 0.2% |
260,446
+145,494
|
|